Your browser doesn't support javascript.
loading
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern.
Li, Wenwei; Chen, Yaozong; Prévost, Jérémie; Ullah, Irfan; Lu, Maolin; Gong, Shang Yu; Tauzin, Alexandra; Gasser, Romain; Vézina, Dani; Anand, Sai Priya; Goyette, Guillaume; Chaterjee, Debashree; Ding, Shilei; Tolbert, William D; Grunst, Michael W; Bo, Yuxia; Zhang, Shijian; Richard, Jonathan; Zhou, Fei; Huang, Rick K; Esser, Lothar; Zeher, Allison; Côté, Marceline; Kumar, Priti; Sodroski, Joseph; Xia, Di; Uchil, Pradeep D; Pazgier, Marzena; Finzi, Andrés; Mothes, Walther.
Affiliation
  • Li W; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Chen Y; Infectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4712, USA.
  • Prévost J; Centre de Recherche du CHUM (CRCHUM), Montreal, QC H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H2X 0A9, Canada.
  • Ullah I; Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Lu M; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Gong SY; Centre de Recherche du CHUM (CRCHUM), Montreal, QC H2X 0A9, Canada; Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 2B4, Canada.
  • Tauzin A; Centre de Recherche du CHUM (CRCHUM), Montreal, QC H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H2X 0A9, Canada.
  • Gasser R; Centre de Recherche du CHUM (CRCHUM), Montreal, QC H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H2X 0A9, Canada.
  • Vézina D; Centre de Recherche du CHUM (CRCHUM), Montreal, QC H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H2X 0A9, Canada.
  • Anand SP; Centre de Recherche du CHUM (CRCHUM), Montreal, QC H2X 0A9, Canada; Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 2B4, Canada.
  • Goyette G; Centre de Recherche du CHUM (CRCHUM), Montreal, QC H2X 0A9, Canada.
  • Chaterjee D; Centre de Recherche du CHUM (CRCHUM), Montreal, QC H2X 0A9, Canada.
  • Ding S; Centre de Recherche du CHUM (CRCHUM), Montreal, QC H2X 0A9, Canada.
  • Tolbert WD; Infectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4712, USA.
  • Grunst MW; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Bo Y; Department of Biochemistry, Microbiology and Immunology, and Center for Infection, Immunity, and Inflammation, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
  • Zhang S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA.
  • Richard J; Centre de Recherche du CHUM (CRCHUM), Montreal, QC H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H2X 0A9, Canada.
  • Zhou F; Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Huang RK; Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Esser L; Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Zeher A; Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Côté M; Department of Biochemistry, Microbiology and Immunology, and Center for Infection, Immunity, and Inflammation, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
  • Kumar P; Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Sodroski J; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA.
  • Xia D; Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Uchil PD; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Pazgier M; Infectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4712, USA. Electronic address: marzena.pazgier@usuhs.edu.
  • Finzi A; Centre de Recherche du CHUM (CRCHUM), Montreal, QC H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H2X 0A9, Canada; Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 2B4, Canada. Electronic address: andres
  • Mothes W; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT 06520, USA. Electronic address: walther.mothes@yale.edu.
Cell Rep ; 38(2): 110210, 2022 01 11.
Article de En | MEDLINE | ID: mdl-34971573
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Cell Rep Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Cell Rep Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique